Massachusetts General Hospital
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Massachusetts General Hospital sits in the top decile of US sponsors by registered trial count (#4 of 15,751 sponsors by registered trial count).
Massachusetts General Hospital: 2,032 sponsored US clinical trials, 336 recruiting.
Massachusetts General Hospital sponsors 2,032 registered US clinical trials on ClinicalTrials.gov, 336 of them currently recruiting, and 1,284 completed. 240 of these trials are in Phase 3-4 (later-stage) and 515 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 29 trials.
Top-decile sponsor footprint
Massachusetts General Hospital ranks in the top decile of sponsors by registered trial count (#4 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
2,032 total, page 31 of 41
Does Percutaneous Tibial Nerve Stimulation (PTNS) Improve Outcomes in Patients Presenting With Fecal Incontinence
NCT01274585
Could Meditation Modulate the Neurobiology of Learning Not to Fear?
NCT01320969
Study to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Elderly Subjects
NCT01274598
DAYLIGHT: Vitamin D Therapy in Individuals at High Risk of Hypertension
NCT01240512
Effects of Growth Hormone Releasing Hormone in HIV
NCT01263717
Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma
NCT01239394
A Novel Approach to Methicillin-resistant Staphylococcus Aureus (MRSA) Screening of Colonized Patients
NCT01234831
N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression
NCT01260649
Efficacy and Safety of Cranial Electrical Stimulation (CES) for Major Depressive Disorder (MDD)
NCT01325532
Pilot Study of Pharmaceutical and Behavioral Interventions to Treat Anxiety Disorders
NCT01631682
Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion
NCT01246011
Individualized Stereotactic Body Radiotherapy of Liver Metastases
NCT01239381
In-Room PET in Proton Radiation Therapy
NCT01228448
Optical Frequency Domain Imaging (OFDI) Surveillance and Image Guided Biopsy of the Esophagus
NCT01439633
Perception Prognosis, Goals of Treatment, and Communication
NCT01401894
Be Fit in Residency: a Randomized Controlled Trial of an Activity Device Among Medicine Residents
NCT01287208
IPI-504 in NSCLC Patients With ALK Translocations
NCT01228435
An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma
NCT01078961
Comparative Effectiveness Study for Bipolar Disorder
NCT01331304
Vitamin D Deficiency in Adolescent Girls
NCT01180946
A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients
NCT01201967
Metformin in Castration-Resistant Prostate Cancer
NCT01215032
Neuroimaging for Depression
NCT00864630
Changes in Brown Adipose Tissue Activity In Men Receiving Androgen Deprivation Therapy for Prostate Cancer
NCT01226888
STA-9090 in Patients With Advanced Hepatocellular Cancer
NCT01665937
Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders
NCT01302964
Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer
NCT01188876
Effectiveness of GSK598809, a Selective D3 Antagonist, Added to CBT and NRT for Smoking Cessation and Relapse Prevention
NCT01188967
Tandem Auto-Allo Transplant for Lymphoma
NCT01181271
Effectiveness of a Relaxation-Response Based Cognitive Behavioral Therapy Group for Depressed Chinese Patients
NCT01359839
STA-9090 in Previously Treated Patients With Advanced Esophagogastric Cancer
NCT01167114
Comparison of Xtreme CT and DXA Bone Densitometry
NCT01199991
Impact of Vitamin D Supplementation on Cardiac Structure and Function
NCT01630213
Selecting Insulin Analogs for Closed-Loop Control Using Multiplex Pharmacokinetic Profiling
NCT01684943
Effects of Blood Transfusion in Healthy Volunteers
NCT01226498
Smoking Interventions for Hospital Patients
NCT01177176
Emotion Regulation Group Therapy for Bipolar Disorder
NCT01207505
Using Videos to Improve Understanding of the Delivery of End-of-life Medical Care in Non-hospital Settings
NCT01233973
Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory CLL and SLL
NCT01173679
Metabolic and Psychological Changes Associated With Menopause Among Women With HIV
NCT01142817
Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia
NCT01082588
Study to Evaluate the Effect of a Nu Skin Product and Device for Brown Spots
NCT01149876
High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma
NCT01182415
Effect of Spinal Cord Stimulation on Pain Thresholds and Sensory Perception in Chronic Pain Patients.
NCT01137617
Ultrasound Method to Measure Fibrosis of the Liver in Children
NCT02086708
Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency Disorders
NCT01165619
Stress Reduction and Anxiety: Effects on the Function and Structure of the Brain
NCT01128309
Pilot Study of Open-label Placebo to Treat Major Depressive Disorder
NCT01103271
Computer Assisted Planing of Corrective Osteotomy for Distal Radius Malunion
NCT01193010
Effects of Estrogen and Hot Flashes on Mood in Postmenopausal Women
NCT01126801
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 226 |
| Phase 2 | 289 |
| Phase 3 | 58 |
| Phase 4 | 182 |
Therapeutic Areas
What is open in the Massachusetts General Hospital pipeline
336 recruiting of 2,032 indexed (17% open); 1,284 completed (63%).
Phase mix: 240 late (III/IV) vs 515 early (I/II) (early-phase heavy).
Top condition: Depression (29 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.